Selected research
Industry Growth & Trends
Global Advanced Therapy Medicinal Products Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Advanced Therapy Medicinal Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Advanced Therapy Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Advanced Therapy Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Advanced Therapy Medicinal Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Advanced Therapy Medicinal Products market include Novartis, Vericel Corporation, UniQure, Spark Therapeutics, PHARMICELL, MEDIPOST, Kolon TissueGene, JCR Pharmaceuticals and Gilead Lifesciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Advanced Therapy Medicinal Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Advanced Therapy Medicinal Products market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Advanced Therapy Medicinal Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Advanced Therapy Medicinal Products.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Advanced Therapy Medicinal Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Advanced Therapy Medicinal Products Market by Company
Novartis
Vericel Corporation
UniQure
Spark Therapeutics
PHARMICELL
MEDIPOST
Kolon TissueGene
JCR Pharmaceuticals
Gilead Lifesciences
Celgene Corporation
Bluebird Bio
Advanced Therapy Medicinal Products Segment by Type
Tissue Engineered Product
Cell Therapy
Gene Therapy
CAR-T Therapy
Advanced Therapy Medicinal Products Segment by Application
Hospital
Clinic
Advanced Therapy Medicinal Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Therapy Medicinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Advanced Therapy Medicinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Therapy Medicinal Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Advanced Therapy Medicinal Products companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tissue Engineered Product
- Cell Therapy
- Gene Therapy
- CAR-T Therapy
Applications
- Hospital
- Clinic
Companies covered
- Novartis
- Vericel Corporation
- UniQure
- Spark Therapeutics
- PHARMICELL
- MEDIPOST
- Kolon TissueGene
- JCR Pharmaceuticals
- Gilead Lifesciences
- Celgene Corporation
- Bluebird Bio
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Advanced Therapy Medicinal Products Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Advanced Therapy Medicinal Products Market Size by Region (2021-2032)
- 1.4.1 Global Advanced Therapy Medicinal Products Market Size by Region (2021-2026)
- 1.4.2 Global Advanced Therapy Medicinal Products Market Size by Region (2027-2032)
- 1.5 Key Regions Advanced Therapy Medicinal Products Market Size (2021-2032)
- 1.5.1 North America Advanced Therapy Medicinal Products Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Advanced Therapy Medicinal Products Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Advanced Therapy Medicinal Products Market Size Growth Rate (2021-2032)
- 1.5.4 South America Advanced Therapy Medicinal Products Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Advanced Therapy Medicinal Products Market Size Growth Rate (2021-2032)
2 Advanced Therapy Medicinal Products Market by Type
- 2.1 Type Introduction
- 2.1.1 Tissue Engineered Product
- 2.1.2 Cell Therapy
- 2.1.3 Gene Therapy
- 2.1.4 CAR-T Therapy
- 2.2 Global Advanced Therapy Medicinal Products Market Size by Type
- 2.2.1 Global Advanced Therapy Medicinal Products Market Size Overview by Type (2021-2032)
- 2.2.2 Global Advanced Therapy Medicinal Products Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Advanced Therapy Medicinal Products Market Size Forecasted by Type (2027-2032)
- 2.3 Global Advanced Therapy Medicinal Products Market Size by Regions
- 2.3.1 North America Advanced Therapy Medicinal Products Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Advanced Therapy Medicinal Products Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Advanced Therapy Medicinal Products Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Advanced Therapy Medicinal Products Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Advanced Therapy Medicinal Products Market Size Breakdown by Type (2021-2026)
3 Advanced Therapy Medicinal Products Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.2 Global Advanced Therapy Medicinal Products Market Size by Application
- 3.2.1 Global Advanced Therapy Medicinal Products Market Size Overview by Application (2021-2032)
- 3.2.2 Global Advanced Therapy Medicinal Products Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Advanced Therapy Medicinal Products Market Size Forecasted by Application (2027-2032)
- 3.3 Global Advanced Therapy Medicinal Products Market Size by Regions
- 3.3.1 North America Advanced Therapy Medicinal Products Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Advanced Therapy Medicinal Products Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Advanced Therapy Medicinal Products Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Advanced Therapy Medicinal Products Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Advanced Therapy Medicinal Products Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Advanced Therapy Medicinal Products Industry Trends
- 4.2 Advanced Therapy Medicinal Products Industry Drivers
- 4.3 Advanced Therapy Medicinal Products Industry Opportunities and Challenges
- 4.4 Advanced Therapy Medicinal Products Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Advanced Therapy Medicinal Products Revenue (2021-2026)
- 5.2 Global Advanced Therapy Medicinal Products Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Advanced Therapy Medicinal Products Key Company Headquarters & Area Served
- 5.4 Global Advanced Therapy Medicinal Products Company, Product Type & Application
- 5.5 Global Advanced Therapy Medicinal Products Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Advanced Therapy Medicinal Products Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Advanced Therapy Medicinal Products Players Market Share by Revenue in 2025
- 5.6.3 2025 Advanced Therapy Medicinal Products Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Novartis
- 6.1.1 Novartis Company Information
- 6.1.2 Novartis Business Overview
- 6.1.3 Novartis Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Novartis Advanced Therapy Medicinal Products Product Portfolio
- 6.1.5 Novartis Recent Developments
- 6.2 Vericel Corporation
- 6.2.1 Vericel Corporation Company Information
- 6.2.2 Vericel Corporation Business Overview
- 6.2.3 Vericel Corporation Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Vericel Corporation Advanced Therapy Medicinal Products Product Portfolio
- 6.2.5 Vericel Corporation Recent Developments
- 6.3 UniQure
- 6.3.1 UniQure Company Information
- 6.3.2 UniQure Business Overview
- 6.3.3 UniQure Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 UniQure Advanced Therapy Medicinal Products Product Portfolio
- 6.3.5 UniQure Recent Developments
- 6.4 Spark Therapeutics
- 6.4.1 Spark Therapeutics Company Information
- 6.4.2 Spark Therapeutics Business Overview
- 6.4.3 Spark Therapeutics Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Spark Therapeutics Advanced Therapy Medicinal Products Product Portfolio
- 6.4.5 Spark Therapeutics Recent Developments
- 6.5 PHARMICELL
- 6.5.1 PHARMICELL Company Information
- 6.5.2 PHARMICELL Business Overview
- 6.5.3 PHARMICELL Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 PHARMICELL Advanced Therapy Medicinal Products Product Portfolio
- 6.5.5 PHARMICELL Recent Developments
- 6.6 MEDIPOST
- 6.6.1 MEDIPOST Company Information
- 6.6.2 MEDIPOST Business Overview
- 6.6.3 MEDIPOST Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 MEDIPOST Advanced Therapy Medicinal Products Product Portfolio
- 6.6.5 MEDIPOST Recent Developments
- 6.7 Kolon TissueGene
- 6.7.1 Kolon TissueGene Company Information
- 6.7.2 Kolon TissueGene Business Overview
- 6.7.3 Kolon TissueGene Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Kolon TissueGene Advanced Therapy Medicinal Products Product Portfolio
- 6.7.5 Kolon TissueGene Recent Developments
- 6.8 JCR Pharmaceuticals
- 6.8.1 JCR Pharmaceuticals Company Information
- 6.8.2 JCR Pharmaceuticals Business Overview
- 6.8.3 JCR Pharmaceuticals Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 JCR Pharmaceuticals Advanced Therapy Medicinal Products Product Portfolio
- 6.8.5 JCR Pharmaceuticals Recent Developments
- 6.9 Gilead Lifesciences
- 6.9.1 Gilead Lifesciences Company Information
- 6.9.2 Gilead Lifesciences Business Overview
- 6.9.3 Gilead Lifesciences Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Gilead Lifesciences Advanced Therapy Medicinal Products Product Portfolio
- 6.9.5 Gilead Lifesciences Recent Developments
- 6.10 Celgene Corporation
- 6.10.1 Celgene Corporation Company Information
- 6.10.2 Celgene Corporation Business Overview
- 6.10.3 Celgene Corporation Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Celgene Corporation Advanced Therapy Medicinal Products Product Portfolio
- 6.10.5 Celgene Corporation Recent Developments
- 6.11 Bluebird Bio
- 6.11.1 Bluebird Bio Company Information
- 6.11.2 Bluebird Bio Business Overview
- 6.11.3 Bluebird Bio Advanced Therapy Medicinal Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Bluebird Bio Advanced Therapy Medicinal Products Product Portfolio
- 6.11.5 Bluebird Bio Recent Developments
7 North America
- 7.1 North America Advanced Therapy Medicinal Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 7.3 North America Advanced Therapy Medicinal Products Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Advanced Therapy Medicinal Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 8.3 Europe Advanced Therapy Medicinal Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Advanced Therapy Medicinal Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Advanced Therapy Medicinal Products Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Advanced Therapy Medicinal Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 10.3 South America Advanced Therapy Medicinal Products Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Advanced Therapy Medicinal Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Advanced Therapy Medicinal Products Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst